Please login to the form below

Not currently logged in
Email:
Password:

Alzheimer's Society

This page shows the latest Alzheimer's Society news and features for those working in and with pharma, biotech and healthcare.

Biogen defends aducanumab filing plan amid scepticism

Biogen defends aducanumab filing plan amid scepticism

A new look at pivotal trial data described as hard-to-interpret. A much-anticipated presentation of data from Biogen’s pivotal trials programme for Alzheimer’s disease candidate aducanumab has ... Dr James Pickett, head of research at Alzheimer’s

Latest news

  • Online therapy for dementia carers to be studied Online therapy for dementia carers to be studied

    The project is being co-led by the Oxford Health NHS Foundation Trust and the Alzheimer’s Society and they’ll assess an online programme called ‘ Caring for Me and You’. ... Dr Doug Brown, director of research and development at the Alzheimer’s

  • Researchers say 'neurostatins' may ward off Alzheimer's Researchers say 'neurostatins' may ward off Alzheimer's

    in a model of Alzheimer's disease (AD) by preventing the production of neurotoxic beta-amyloid aggregates. ... A note of caution has been sounded by Doug Brown, R&D director at the Alzheimer's Society, who noted that Bexarotene has many side effects

  • Glimmer of hope for amyloid drugs in Alzheimer's? Glimmer of hope for amyloid drugs in Alzheimer's?

    Clinical trials have provided some preliminary evidence that drugs targeting amyloid may help delay Alzheimer's disease (AD), although scientists stress it is far too early to draw conclusions. ... The trial still has another two years to run. The

  • Charity coalition pledges millions for brain disease research Charity coalition pledges millions for brain disease research

    The funding will focus on neurodegenerative conditions, such as dementia, motor neurone disease and Parkinson's disease for which there is an unmet need. ... Neuro–MAP's partners are Alzheimer's Association US, Alzheimer Research UK, Alzheimer's

  • Boehringer gets ‘kite mark’ for health information Boehringer gets ‘kite mark’ for health information

    Organisations signed up to the TIS include charities, such as the Alzheimer's Society and the British Liver trust, private healthcare provider Bupa and many NHS trusts, but Boehringer is the ... And to do so, it's vital that all parties have the right

More from news
Approximately 1 fully matching, plus 29 partially matching documents found.

Latest Intelligence

  • What can pharma learn from the charity sector? What can pharma learn from the charity sector?

    Georgina Carr, Head of External Relations and Campaigns at the MS Society, works with people with MS on a daily basis: “Co-creation has been key in the health charity sector ... Dr Doug Brown, Chief Policy and Research Officer at Alzheimer’s Society,

  • Holding on to hope for Alzheimer’s advances Holding on to hope for Alzheimers advances

    750 people with prodromal to mild Alzheimer’s; that too is scheduled to complete in 2020. ... The project is a joint £250m investment into dementia research led by the Medical Research Council, alongside the Alzheimer’s Society and Alzheimer’s

  • Boehringer Ingelheim on walking the talk in patient-centricity Boehringer Ingelheim on walking the talk in patient-centricity

    The role is the first position at the company that Dugi has taken outside Boehringer's homeland. ... In signing up to The Information Standard, Boehringer joins the likes of the Alzheimer's Society and the British Liver Trust, private healthcare provider

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • UK Dementia Research Institute names director UK Dementia Research Institute names director

    In his new role, Prof De Strooper will work with the institute's founding partners - the Medical Research Council, Alzheimer's Society and Alzheimer's Research UK - to develop new therapeutics

  • NHiS appoints mental health associate director NHiS appoints mental health associate director

    During this time, he has worked closely with local authorities to publish the Merton Mental Health Needs Assessment and helped to develop the Alzheimer's Society's Dementia Hub. ... capability. “Following Laurence's appointment, we can now offer

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Mednet Group Mednet Group

    Alzheimer’s Research UK. Alzheimer’s Society. Basic Needs. Biogen. Butterfly Scheme. Cardiomyopathy UK. ... Marketing Design Awards. New York Festivals. PM Society Advertising Awards. PM Society Digital Awards.

  • emotive choose a charity to support in 2016

    A total of 24 charities were put forward and vigorously defended, including Crisis, Alzheimer’s Society, Stroke Association, War Child, Orangutan Foundation, Age UK, Solar Aid, and Battersea Dogs and Cats ... Adam Boucher, emotive’s Client Services

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....